$NHHS
NorthStar Healthcare Income, Inc.

2022 Q3 Form 10-Q Financial Statement

#000150370722000026 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $47.74M $45.37M $43.33M
YoY Change -25.89% -29.0% -24.42%
Cost Of Revenue $35.13M $33.23M $32.89M
YoY Change -23.26% -26.32% -27.89%
Gross Profit $12.61M $12.14M $10.44M
YoY Change -32.34% -35.42% -10.91%
Gross Profit Margin 26.4% 26.76% 24.09%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.642M $9.540M $9.923M
YoY Change -30.27% -38.68% -35.51%
% of Gross Profit 76.49% 78.56% 95.07%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $11.01M $10.55M $10.31M
YoY Change -30.2% -33.88% -35.67%
% of Operating Profit
Other Income/Expense, Net $0.00 $5.000K $72.00K
YoY Change -101.07% -99.02%
Pretax Income -$32.37M -$27.41M -$15.47M
YoY Change 64.84% 54.4% 67.22%
Income Tax $15.00K $15.00K $15.00K
% Of Pretax Income
Net Earnings -$29.51M $6.627M -$12.98M
YoY Change 151.11% -194.7% 27.83%
Net Earnings / Revenue -61.82% 14.61% -29.96%
Basic Earnings Per Share -$0.15 $0.04 -$0.07
Diluted Earnings Per Share -$0.15 $0.04 -$0.07
COMMON SHARES
Basic Shares Outstanding 194.7M shares 194.0M shares 193.4M shares
Diluted Shares Outstanding 194.7M shares 194.0M shares 193.4M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $95.15M $105.4M $191.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $2.337M $2.421M $2.506M
YoY Change
Long-Term Investments $205.2M $208.0M $207.4M
YoY Change -7.12% -7.44% -6.54%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.259B $1.291B $1.391B
YoY Change -30.74% -30.99% -26.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $942.2M $944.7M $954.8M
YoY Change -34.03% -35.76% -35.42%
SHAREHOLDERS EQUITY
Retained Earnings -$1.410B -$1.381B -$1.291B
YoY Change 5.9% 4.6% -1.72%
Common Stock $1.730B $1.728B $1.725B
YoY Change 0.61% 0.63% 0.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $314.9M $343.6M $433.7M
YoY Change
Total Liabilities & Shareholders Equity $1.259B $1.291B $1.391B
YoY Change -30.74% -30.99% -26.11%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$29.51M $6.627M -$12.98M
YoY Change 151.11% -194.7% 27.83%
Depreciation, Depletion And Amortization $9.642M $9.540M $9.923M
YoY Change -30.27% -38.68% -35.51%
Cash From Operating Activities -$10.84M
YoY Change 62.81%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $4.716M
YoY Change -89.44%
FINANCING ACTIVITIES
Cash Dividend Paid $97.00M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$4.297M
YoY Change -78.88%
NET CHANGE
Cash From Operating Activities -$10.84M
Cash From Investing Activities $4.716M
Cash From Financing Activities -$4.297M
Net Change In Cash -$10.42M
YoY Change -158.99%
FREE CASH FLOW
Cash From Operating Activities -$10.84M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#RealEstateInvestmentPropertyNet
dei Entity Central Index Key
EntityCentralIndexKey
0001503707
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilities
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55190
dei Entity Registrant Name
EntityRegistrantName
NORTHSTAR HEALTHCARE INCOME, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3663988
dei Entity Address Address Line1
EntityAddressAddressLine1
4350 East West Highway
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1050
dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20814
dei City Area Code
CityAreaCode
240
dei Local Phone Number
LocalPhoneNumber
479-7115
dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
194666180 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105431000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
200473000 usd
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
11646000 usd
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
10465000 usd
CY2022Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
952009000 usd
CY2021Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
972599000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2590000 usd
CY2022Q2 us-gaap Other Assets
OtherAssets
7248000 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
208030000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
212309000 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
3757000 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3666000 usd
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2421000 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
10771000 usd
CY2022Q2 us-gaap Assets
Assets
1290542000 usd
CY2021Q4 us-gaap Assets
Assets
1412873000 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
919525000 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
929811000 usd
CY2022Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
3769000 usd
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
7338000 usd
CY2022Q2 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
1113000 usd
CY2021Q4 us-gaap Advance Payments By Borrowers For Taxes And Insurance
AdvancePaymentsByBorrowersForTaxesAndInsurance
1171000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
17472000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
24671000 usd
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
2854000 usd
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
3064000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
944733000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
966055000 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
194456480 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
194456480 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
193120940 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
193120940 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1945000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1930000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1725976000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1720719000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1380869000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1277688000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3424000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-486000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
343628000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
444475000 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
2181000 usd
CY2021Q4 us-gaap Minority Interest
MinorityInterest
2343000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
345809000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
446818000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1290542000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1412873000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10958000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28254000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
21713000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
56536000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000 usd
CY2022Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
34277000 usd
CY2021Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
35612000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
66836000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
64663000 usd
CY2022Q2 us-gaap Other Operating Income
OtherOperatingIncome
139000 usd
CY2021Q2 us-gaap Other Operating Income
OtherOperatingIncome
41000 usd
us-gaap Other Operating Income
OtherOperatingIncome
157000 usd
us-gaap Other Operating Income
OtherOperatingIncome
42000 usd
CY2022Q2 us-gaap Revenues
Revenues
45374000 usd
CY2021Q2 us-gaap Revenues
Revenues
63907000 usd
us-gaap Revenues
Revenues
88706000 usd
us-gaap Revenues
Revenues
121241000 usd
CY2022Q2 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
0 usd
CY2021Q2 us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
1387000 usd
us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
0 usd
us-gaap Interest Income Debt Securities Operating
InterestIncomeDebtSecuritiesOperating
3600000 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33230000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
77000 usd
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45101000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
66124000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
90719000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
10554000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
15962000 usd
us-gaap Interest Expense
InterestExpense
20863000 usd
us-gaap Interest Expense
InterestExpense
31987000 usd
CY2022Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
54000 usd
CY2022Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2457000 usd
CY2021Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2769000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
5104000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
5538000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3755000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3079000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7441000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6112000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9540000 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15557000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19463000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30944000 usd
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
13002000 usd
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
13002000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
786000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
72538000 usd
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
82468000 usd
us-gaap Costs And Expenses
CostsAndExpenses
131997000 usd
us-gaap Costs And Expenses
CostsAndExpenses
166140000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-468000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6892000 usd
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-252000 usd
CY2021Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-111000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
335000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
7404000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-27411000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17753000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-42879000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-27003000 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
34053000 usd
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10766000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
36555000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9876000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
6627000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6998000 usd
us-gaap Profit Loss
ProfitLoss
-6354000 usd
us-gaap Profit Loss
ProfitLoss
-17153000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-180000 usd
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-135000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-225000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
173000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6807000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
6807000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6863000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6863000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6129000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6129000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17326000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-17326000 usd
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
194044709 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
194044709 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
191273318 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
191273318 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
193708466 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
193708466 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000000000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
190953795 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
190953795 shares
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
49872 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
66840 shares
CY2022Q2 us-gaap Profit Loss
ProfitLoss
6627000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6998000 usd
us-gaap Profit Loss
ProfitLoss
-6354000 usd
us-gaap Profit Loss
ProfitLoss
-17153000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2370000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-108000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2938000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-582000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2370000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-108000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2938000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-582000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
4257000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-7106000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-9292000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-17735000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-180000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-135000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-225000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
173000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4437000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6971000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9067000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17908000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
412062000 usd
CY2021Q1 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46000 usd
CY2021Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
240000 usd
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
350000 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-474000 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-10155000 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
403869000 usd
CY2021Q2 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2500000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
73000 usd
CY2021Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
146000 usd
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
33000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-108000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6998000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
399449000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
446818000 usd
CY2022Q1 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2729000 usd
CY2022Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
64000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
53000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-568000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-12981000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
436024000 usd
CY2022Q2 nshi Stock Redeemedor Called During Period Value Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodValuePaymentofAdvisorAssetManagementFees
2515000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000 usd
CY2022Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
113000 usd
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
61000 usd
CY2022Q2 us-gaap Dividends
Dividends
97052000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2370000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
6627000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
345809000 usd
us-gaap Profit Loss
ProfitLoss
-6354000 usd
us-gaap Profit Loss
ProfitLoss
-17153000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
36555000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9876000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19463000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30944000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
13002000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
786000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1614000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1575000 usd
us-gaap Straight Line Rent
StraightLineRent
0 usd
us-gaap Straight Line Rent
StraightLineRent
-7085000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
243000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
312000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
932000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
93000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
119000 usd
nshi Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal
PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal
0 usd
nshi Paid In Kind Interest Added To Real Estate Debt Investment Loan Principal
PaidInKindInterestAddedToRealEstateDebtInvestmentLoanPrincipal
194000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-3432000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-4624000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
335000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
7404000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
186000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-845000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
5104000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
5000000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
277000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1512000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3838000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4727000 usd
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
-58000 usd
nshi Increase Decreasein Escrow Payable
IncreaseDecreaseinEscrowPayable
341000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8735000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6210000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
32000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
169000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12102000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2813000 usd
nshi Paymentsto Improve Real Estate
PaymentstoImproveRealEstate
10660000 usd
nshi Paymentsto Improve Real Estate
PaymentstoImproveRealEstate
10093000 usd
nshi Proceeds From Sale Of Real Estate Investing
ProceedsFromSaleOfRealEstateInvesting
0 usd
nshi Proceeds From Sale Of Real Estate Investing
ProceedsFromSaleOfRealEstateInvesting
28078000 usd
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
0 usd
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
46631000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
250000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
38140000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
3029000 usd
nshi Proceeds From Real Estate Debt Investment Modification Fee
ProceedsFromRealEstateDebtInvestmentModificationFee
0 usd
nshi Proceeds From Real Estate Debt Investment Modification Fee
ProceedsFromRealEstateDebtInvestmentModificationFee
559000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
27480000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
67954000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
26000000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
12012000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
53361000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
708000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
272000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
295000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
97018000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
177000 usd
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
386000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
114000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
383000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-109239000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-28361000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-93861000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36780000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
210938000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
93570000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117077000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
130350000 usd
us-gaap Interest Paid Net
InterestPaidNet
18725000 usd
us-gaap Interest Paid Net
InterestPaidNet
53140000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
23000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
10000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1047000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
561000 usd
nshi Accrued Distribution Payable
AccruedDistributionPayable
34000 usd
nshi Accrued Distribution Payable
AccruedDistributionPayable
0 usd
us-gaap Nature Of Operations
NatureOfOperations
Business and Organization<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NorthStar Healthcare Income, Inc., together with its consolidated subsidiaries (the “Company”), manages a diversified portfolio of investments in healthcare real estate, owned directly or through joint ventures, with a focus on the mid-acuity seniors housing sector, which the Company defines as assisted living (“ALF”), memory care (“MCF”), skilled nursing (“SNF”), independent living facilities (“ILF”) and continuing care retirement communities (“CCRC”), which have independent living, assisted living, skilled nursing and memory care available on one campus. Primarily through joint ventures, the Company is also invested in other healthcare property types, including medical office buildings (“MOB”), hospitals, rehabilitation facilities and ancillary healthcare services businesses. The Company’s investments are predominantly in the United States, but through its joint ventures also has international investments in the United Kingdom. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable year ended December 31, 2013. The Company has conducted its operations, and intends to do so in the future, so as to continue to qualify as a REIT for U.S. federal income tax purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC (the “Prior Advisor”) and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”), each an affiliate of the Sponsor. The Prior Advisor invested $1,000 in the Operating Partnership in exchange for common units and the Special Unit Holder invested $1,000 in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of June 30, 2022 and December 31, 2021. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of June 30, 2022, the Company’s limited partnership interest in the Operating Partnership was 99.99%.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s charter authorizes the issuance of up to 400.0 million shares of common stock with a par value of $0.01 per share and up to 50.0 million shares of preferred stock with a par value of $0.01 per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is externally managed and has no employees. On February 28, 2022, the Company’s former Sponsor, DigitalBridge Group, Inc. (NYSE: DBRG) (the “Former Sponsor”), completed the previously announced disposition of its wellness infrastructure platform (the “Sponsor Transaction”). Following completion of the Sponsor Transaction, NRF Holdco, LLC (“NRF” or the “New Sponsor”) (and together with the Former Sponsor, the Sponsor as the context requires), owns the Company’s advisor, CNI NSHC Advisors, LLC (the “Advisor”), as well as its own diversified portfolio of medical office buildings, senior housing facilities, skilled nursing facilities and specialty hospitals. NRF is wholly owned by CWP Bidco LP, an entity affiliated with Highgate, a privately held real estate investment and hospitality management company, and Aurora Health Network LLC, a privately held healthcare-focused investment firm. In addition, upon completion of the Sponsor Transaction, employees of the Former Sponsor focused on the wellness infrastructure platform became employees of the New Sponsor. The Advisor, now a subsidiary of the New Sponsor, continues to manage the Company’s day-to-day operations pursuant to an advisory agreement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From inception through June 30, 2022, the Company raised $2.0 billion in total gross proceeds from the sale of shares of common stock in its continuous, public offerings (the “Offering”), including $232.6 million pursuant to its distribution reinvestment plan (the “DRP”). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact of COVID-19</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The world continues to experience the broad effects of the coronavirus 2019 (“COVID-19”) pandemic. The Company's healthcare real estate business and investments have been challenged by suboptimal occupancy levels, lower labor force participation rates, which has driven increased labor costs, and inflationary pressures on other operating expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The continuing impact of the COVID-19 pandemic on the Company’s operational and financial performance will depend on a variety of factors, which may differ considerably across regions and fluctuate over time. An extended recovery period increases the risk of a prolonged negative impact on the Company’s financial condition and results of operations. While the Company has </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the ability to meet its near term liquidity needs, general market concerns over credit and liquidity continue, and the effects of COVID-19 may also lead to heightened risk of litigation, with an ensuing increase in litigation and related costs.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, the progression of the global economic recovery from the broad effects of COVID-19 remains difficult for the Company to assess and estimate the future impact of COVID-19 on the Company's results of operations. Accordingly, any estimates of the effects of COVID-19 as reflected or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Quarterly Report on Form 10-Q, and such estimates may change, the effects of which could be material. The Company will continue to monitor the progression of the economic recovery from COVID-19 and reassess its effects on the Company’s results of operations and recoverability of value across its assets as conditions change.</span></div>
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
208000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions. Any estimates of the effects of COVID-19 pandemic, inflation, rising interest rates, risk of recession and other economic conditions as reflected and/or discussed in these financial statements are based upon the Company's best estimates using information known to the Company as of the date of this Quarterly Report on Form 10-Q. Such estimates may change and the impact of which could be material.</span></div>
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
24000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105431000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
200473000 usd
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
11646000 usd
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
10465000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117077000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
210938000 usd
CY2022Q2 nshi Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
28000 usd
CY2022Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2500000 usd
nshi Finance Lease Payments
FinanceLeasePayments
300000 usd
nshi Finance Lease Payments
FinanceLeasePayments
300000 usd
CY2021Q2 nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
500000 usd
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
900000 usd
CY2022Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
202000 usd
CY2022Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
93000 usd
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
60000 usd
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
29000 usd
CY2022Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
436000 usd
CY2022Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
33000 usd
CY2022Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
403000 usd
CY2022Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.067
CY2022Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
us-gaap Asset Impairment Charges
AssetImpairmentCharges
800000 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2022Q2 nshi Number Of Triple Net Lease Portfolios
NumberOfTripleNetLeasePortfolios
4 portfolio
CY2022Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense After Year Four
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
904000 usd
CY2022Q2 nshi Deferred Costsand Finite Lived Intangible Assets Net
DeferredCostsandFiniteLivedIntangibleAssetsNet
2421000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
117728000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
117559000 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2421000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2590000 usd
CY2022Q2 nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
100000 usd
nshi Amortizationof Deferred Costsand Intangible Assets
AmortizationofDeferredCostsandIntangibleAssets
200000 usd
CY2022Q2 nshi Deferred Costsand Finite Lived Intangible Assets Amortization Expense Remainderof Fiscal Year
DeferredCostsandFiniteLivedIntangibleAssetsAmortizationExpenseRemainderofFiscalYear
169000 usd
CY2022Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year One
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearOne
337000 usd
CY2022Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Two
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
337000 usd
CY2022Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Three
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearThree
337000 usd
CY2022Q2 nshi Deferred Costs And Finite Lived Intangible Assets Amortization Expense Year Four
DeferredCostsAndFiniteLivedIntangibleAssetsAmortizationExpenseYearFour
337000 usd
CY2022Q2 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 d
CY2022Q2 nshi Lease Terms Days Notice Required For Termination
LeaseTermsDaysNoticeRequiredForTermination
30 d
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
7100000 usd
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
6700000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
13000000 usd
nshi Impairment Charges For Property Damages
ImpairmentChargesForPropertyDamages
600000 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q2 nshi Acquisition Feeand Expense Cap
AcquisitionFeeandExpenseCap
0.060
CY2022Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1196605000 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
13900000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 usd
CY2021Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1197900000 usd
CY2022Q2 us-gaap Land
Land
121518000 usd
CY2021Q4 us-gaap Land
Land
121518000 usd
CY2022Q2 us-gaap Land Improvements
LandImprovements
18027000 usd
CY2021Q4 us-gaap Land Improvements
LandImprovements
17798000 usd
CY2022Q2 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
961506000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
13000000 usd
CY2021Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
965630000 usd
CY2022Q2 us-gaap Tenant Improvements
TenantImprovements
251000 usd
CY2021Q4 us-gaap Tenant Improvements
TenantImprovements
0 usd
CY2022Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
7842000 usd
CY2021Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
8141000 usd
CY2022Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
87461000 usd
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
84813000 usd
CY2022Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
244596000 usd
CY2021Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
225301000 usd
CY2022Q2 us-gaap Real Estate Investments
RealEstateInvestments
952009000 usd
CY2021Q4 us-gaap Real Estate Investments
RealEstateInvestments
972599000 usd
CY2022Q2 us-gaap Depreciation
Depreciation
9500000 usd
us-gaap Depreciation
Depreciation
19300000 usd
CY2021Q2 us-gaap Depreciation
Depreciation
15100000 usd
us-gaap Depreciation
Depreciation
30000000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
800000 usd
CY2022Q2 us-gaap Equity Method Investments
EquityMethodInvestments
208030000 usd
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
212309000 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
34053000 usd
CY2022Q2 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
31087000 usd
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10766000 usd
CY2021Q2 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2170000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
36555000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
38140000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9876000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3029000 usd
nshi Related Party Transaction Dueto Related Parties Amount Paid
RelatedPartyTransactionDuetoRelatedPartiesAmountPaid
14929000 usd
CY2022Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
3769000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
9449000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
31032000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
20406000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
670302000 usd
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
46964000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
118833 usd
CY2022Q2 nshi Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
153399000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
931552000 usd
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
7338000 usd
nshi Related Party Transaction Dueto Related Parties Amount Incurred
RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred
11360000 usd
nshi Stock Redeemedor Called During Period Shares Paymentof Advisor Asset Management Fees
StockRedeemedorCalledDuringPeriodSharesPaymentofAdvisorAssetManagementFees
1300000 shares
nshi Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Shares Issuedas Paymentfor Asset Management Fees
NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSharesIssuedasPaymentforAssetManagementFees
5200000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
45667 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
73208 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
93167 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
325000 usd
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
223167 usd
CY2022Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.50
CY2022Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
97100000 usd
CY2022Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
97000000 usd
CY2022Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
33419 usd
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
122900000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-200000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-200000 usd
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-100000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
200000 usd
nshi Impairment Charges For Property Damages
ImpairmentChargesForPropertyDamages
600000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
5 segment
CY2022Q2 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
45374000 usd
CY2022Q2 us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33230000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
10554000 usd
CY2022Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2022Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2457000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3755000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9540000 usd
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
13002000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000 usd
CY2022Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-252000 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
34053000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
6627000 usd
CY2021Q2 nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
63907000 usd
CY2021Q2 us-gaap Interest Income Operating
InterestIncomeOperating
1387000 usd
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
45101000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
15962000 usd
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2021Q2 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
2769000 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3079000 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15557000 usd
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-468000 usd
CY2021Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-111000 usd
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10766000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-6998000 usd
nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
88706000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
66124000 usd
us-gaap Interest Expense
InterestExpense
20863000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
5104000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7441000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19463000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
13002000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
77000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
335000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
36555000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000 usd
us-gaap Profit Loss
ProfitLoss
-6354000 usd
nshi Rentaland Resident Fee Income
RentalandResidentFeeIncome
121241000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
3600000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
90719000 usd
us-gaap Interest Expense
InterestExpense
31987000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
54000 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
5538000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6112000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30944000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
786000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6892000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
7404000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9876000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 usd
us-gaap Profit Loss
ProfitLoss
-17153000 usd
CY2022Q2 us-gaap Assets
Assets
1290542000 usd
CY2021Q4 us-gaap Assets
Assets
1412873000 usd
CY2022Q2 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
56 property
CY2022Q2 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
6822 unit
us-gaap Noninterest Income
NoninterestIncome
88706000 usd

Files In Submission

Name View Source Status
0001503707-22-000026-index-headers.html Edgar Link pending
0001503707-22-000026-index.html Edgar Link pending
0001503707-22-000026.txt Edgar Link pending
0001503707-22-000026-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nshi-20220630.htm Edgar Link pending
nshi-20220630.xsd Edgar Link pending
nshi-20220630_g1.jpg Edgar Link pending
nshi-20220630_g2.jpg Edgar Link pending
nshi06302022exhibit311.htm Edgar Link pending
nshi06302022exhibit312.htm Edgar Link pending
nshi-20220630_def.xml Edgar Link unprocessable
nshi-20220630_cal.xml Edgar Link unprocessable
nshi-20220630_pre.xml Edgar Link unprocessable
nshi-20220630_lab.xml Edgar Link unprocessable
nshi-20220630_htm.xml Edgar Link completed
nshi06302022exhibit321.htm Edgar Link pending
nshi06302022exhibit322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable